Emerging Radiopharmaceuticals and Molecular Imaging

Radiopharmaceuticals and molecular imaging techniques are advancing rapidly, offering unprecedented precision in cancer detection, staging, and therapy planning. These specialized agents bind to tumor-specific receptors or metabolic pathways, enabling highly sensitive imaging modalities such as PET and SPECT to visualize cancer activity at the molecular level. Emerging radiopharmaceuticals not only detect disease earlier but also provide critical information about tumor aggressiveness, treatment response, and metastatic potential.

    Related Conference of Emerging Radiopharmaceuticals and Molecular Imaging

    December 08-09, 2025

    13th Euro Breast Cancer and Therapeutics

    Paris, France
    February 05-06, 2026

    11th World Conference on Breast and Cervical Cancer

    Paris, France
    February 19-20, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    February 19-20, 2026

    8th International Conference on Women Oncology

    Miami, USA
    March 09-10, 2026

    4th World Congress on Oral Cancer

    Singapore City, Singapore
    June 15-16, 2026

    10th Global Meeting on Oncology and Radiology

    Paris, France
    June 22-23, 2026

    16th World Congress on Breast Cancer

    Dubai, UAE
    July 27-28, 2026

    6th World Congress on Breast Cancer

    Rome, Italy
    September 28-29, 2026

    36th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    September 29-30, 2026

    5th Experts Meeting on Cancer Medicine, Radiology & Treatment

    Aix-en-Provence, France

    Emerging Radiopharmaceuticals and Molecular Imaging Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in